Key result
Microneurographic sympathetic nerve activity was higher in chronic kidney disease patients compared to healthy individuals and increased as kidney function declined.
Why the study?
Although microneurographic sympathetic nerve activity (MSNA) recordings show sympathetic overactivation in CKD patients, the relationship between MSNA, renal function, and other risk factors has not been systematically reviewed.
Is microneurographic sympathetic nerve activity (MSNA) increased in cardiovascular complications-free CKD patients compared to healthy individuals?
Meta-Analysis (n=1,010)
Is microneurographic sympathetic nerve activity (MSNA) increased in cardiovascular complications-free CKD patients compared to healthy individuals?
Answers are grounded in this paper and cite their sources.
Sympathetic nerve activity is markedly increased in CKD patients independent of comorbidities and intensifies as renal function declines.
BACKGROUND: Studies based on microneurographic sympathetic nerve activity (MSNA) recordings have shown that the sympathetic system is overactivated in chronic kidney disease (CKD) patients but the relationship between MSNA and renal function and other risk factors has not been systematically reviewed in this population. DESIGN AND MEASUREMENTS: This meta-analysis compares MSNA in cardiovascular complications-free CKD patients (n = 638) and healthy individuals (n = 372) and assesses the relationship of MSNA with the eGFR, age, BMI and hemodynamic variables. RESULTS: In a global analysis, MSNA was higher in CKD patients than in healthy control individuals (P < 0.001). The difference in MSNA between patients and healthy individuals was more marked in end-stage kidney diseases patients than in stage 3A 3B CKD patients (P < 0.001). In an analysis combining patients and healthy individuals, MSNA rose gradually across progressively lower eGFR categories (P < 0.01). In separate meta-regression analyses in CKD patients and in healthy individuals, MSNA associated directly with age (CKD: r = 0.57, P = 0.022; healthy individuals: r = 0.71, P = 0.031) and with the BMI (r = 0.75, P = 0.001 and r = 0.93, P = 0.003). In both groups, MSNA correlated with heart rate (r = 0.77, P = 0.02 and r = 0.66, P = 0.01) but was unrelated to plasma norepinephrine. CONCLUSION: Independently of comorbidities, MSNA is markedly increased in CKD patients as compared with healthy individuals and it is related to renal function, age, the BMI and heart rate. Sympathetic activation intensifies as CKD progresses toward kidney failure and such an intensification is paralleled by a progressive rise in heart rate but it is not reflected by plasma norepinephrine.
No takes yet. Share an insight, caveat, or question.
Grassı et al. (2020) conducted a meta-analysis in Chronic kidney disease (n=1,010). Chronic kidney disease vs. Healthy individuals was evaluated on Microneurographic sympathetic nerve activity (MSNA) (p=<0.001). Microneurographic sympathetic nerve activity was higher in chronic kidney disease patients compared to healthy individuals and increased as kidney function declined.
Synapse has enriched 10 related papers. Consider them for comparative context: